advertisement

Oculus

11.4 Prostaglandins (72)

Showing records 1 to 25

Display all abstracts in classification 11.4 Prostaglandins

Search within classification 11.4 Prostaglandins
79246 Objective ocular surface tolerance in patients with glaucoma treated with topical preserved or unpreserved prostaglandin analogues
El Ameen A
European Journal of Ophthalmology 2018; 0: 1120672118805877
78953 Comparative Effectiveness of Generic Latanoprost Versus Branded Prostaglandin Analogs for Primary Open Angle Glaucoma
Kim DH
Ophthalmic Epidemiology 2019; 26: 63-71
78817 Ocular hypotensive effects of prostaglandin analogs in Japanese patients with normal-tension glaucoma: a literature review
Takagi Y
Clinical Ophthalmology 2018; 12: 1837-1844
79295 Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma
Aspberg J
Journal of Glaucoma 2018; 27: 976-980
78523 Tear biomarkers in latanoprost and bimatoprost treated eyes
Reddy S
PLoS ONE 2018; 13: e0201740
79295 Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma
Aspberg J
Journal of Glaucoma 2018; 27: 976-980
78941 A Long-term Safety Study of Latanoprost in Pediatric Patients With Glaucoma and Ocular Hypertension: A Prospective Cohort Study
Younus M
American Journal of Ophthalmology 2018; 196: 101-111
79202 Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues
Seal JR
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 50-57
78821 Experimental Evaluation of Travoprost-Induced Changes in Biomechanical Behavior of Ex-Vivo Rabbit Corneas
Zheng X
Current Eye Research 2018; 0: 1-6
78786 Washout Duration of Prostaglandin Analogues: A Systematic Review and Meta-analysis
Diaconita V
Journal of Ophthalmology 2018; 2018: 3190684
78389 Effects of sustained daily latanoprost application on anterior chamber anatomy and physiology in mice
Dutca LM
Scientific reports 2018; 8: 13088
78899 Investigational drugs targeting prostaglandin receptors for the treatment of glaucoma
Matsou A
Expert Opinion on Investigational Drugs 2018; 27: 777-785
79295 Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma
Aspberg J
Journal of Glaucoma 2018; 27: 976-980
78946 The Diurnal and Nocturnal Effects of Pilocarpine on Intraocular Pressure in Patients Receiving Prostaglandin Analog Monotherapy
Seibold LK
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 590-595
78389 Effects of sustained daily latanoprost application on anterior chamber anatomy and physiology in mice
Rudd D
Scientific reports 2018; 8: 13088
78899 Investigational drugs targeting prostaglandin receptors for the treatment of glaucoma
Anastasopoulos E
Expert Opinion on Investigational Drugs 2018; 27: 777-785
78946 The Diurnal and Nocturnal Effects of Pilocarpine on Intraocular Pressure in Patients Receiving Prostaglandin Analog Monotherapy
Wagner BD
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 590-595
79246 Objective ocular surface tolerance in patients with glaucoma treated with topical preserved or unpreserved prostaglandin analogues
Vandermeer G
European Journal of Ophthalmology 2018; 0: 1120672118805877
78953 Comparative Effectiveness of Generic Latanoprost Versus Branded Prostaglandin Analogs for Primary Open Angle Glaucoma
Addis VM
Ophthalmic Epidemiology 2019; 26: 63-71
78941 A Long-term Safety Study of Latanoprost in Pediatric Patients With Glaucoma and Ocular Hypertension: A Prospective Cohort Study
Schachar RA
American Journal of Ophthalmology 2018; 196: 101-111
78817 Ocular hypotensive effects of prostaglandin analogs in Japanese patients with normal-tension glaucoma: a literature review
Santo K
Clinical Ophthalmology 2018; 12: 1837-1844
79295 Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma
Heijl A
Journal of Glaucoma 2018; 27: 976-980
78523 Tear biomarkers in latanoprost and bimatoprost treated eyes
Sahay P
PLoS ONE 2018; 13: e0201740
78786 Washout Duration of Prostaglandin Analogues: A Systematic Review and Meta-analysis
Quinn M
Journal of Ophthalmology 2018; 2018: 3190684
79202 Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues
Robinson MR
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 50-57

Issue 20-1

Select Issue


advertisement

HaagStreit